Clinton Group’s Merck MRK Stock Holding History

Clinton Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$1.2M	Sell	17,709 -78,807	-82%	-$5.02M	0.43%	67
2018 Q2	$5.59M	Sell	96,516 -30,729	-24%	-$1.73M	0.87%	12
2018 Q1	$6.61M	Buy	127,245 +70,482	+124%	+$3.81M	0.71%	30
2017 Q4	$3.05M	Buy	+56,763	New	+$3.15M	0.27%	123
2017 Q3	–	Sell	-46,182	Closed	-$2.82M	–	530
2017 Q2	$2.82M	Sell	46,182 -135,845	-75%	-$8.27M	0.29%	113
2017 Q1	$11M	Buy	182,027 +97,260	+115%	+$5.9M	0.64%	16
2016 Q4	$4.76M	Buy	+84,767	New	+$4.96M	0.28%	108
2016 Q1	–	Sell	-96,779	Closed	-$4.88M	–	946
2015 Q4	$4.88M	Buy	+96,779	New	+$4.88M	0.4%	48
2015 Q3	–	Sell	-22,651	Closed	-$1.23M	–	786
2015 Q2	$1.23M	Buy	+22,651	New	+$1.27M	0.17%	175
2015 Q1	–	Sell	-15,175	Closed	-$822K	–	566
2014 Q4	$822K	Sell	15,175 -5,751	-27%	-$320K	0.26%	115
2014 Q3	$1.18M	Buy	+20,926	New	+$1.18M	0.48%	38

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clinton Group's MRK Position: Q3 2018 in Review

Clinton Group reduced its Merck (MRK) stake by 82% in Q3 2018, selling an estimated $5.02M and leaving 17,709 shares worth $1.2M. The position accounts for 0.43% of the portfolio, ranked #67.

Clinton Group first reported a position in MRK in Q3 2014 and has held it in 11 quarters since. The position peaked at $11M in Q1 2017. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

Clinton Group held 17,709 shares of Merck worth $1.2M as of Q3 2018.
Clinton Group sold 78,807 Merck shares in Q3 2018, an estimated $5.02M.
Merck made up 0.43% of Clinton Group's portfolio in Q3 2018, its #67 holding.
Clinton Group first reported a position in Merck in Q3 2014 and has held it in 11 quarters since.
Clinton Group's Merck position peaked at $11M in Q1 2017.
2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.